X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc.verified

XFOR

Price:

$0.999

Market Cap:

$167.77M

X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome; and Phase Ib clinical trial to treat chronic neutropenia and Waldenström macroglobulinemia. The company is also developing X4P-002, a CXCR4 antagonist for the treatment of brain cancers; and X4P-003, a CXCR4 antagonist for the t...[Read more]

Industry

Biotechnology

IPO Date

2017-11-16

Stock Exchange

NASDAQ

Ticker

XFOR

The Current Ratio as of June 2024 (TTM) for X4 Pharmaceuticals, Inc. (XFOR) is 3.71

According to X4 Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.71. This represents a change of -30.98% compared to the average of 5.37 of the last 4 quarters.

X4 Pharmaceuticals, Inc. (XFOR) Historical Current Ratio (quarterly & annually)

How has XFOR Current Ratio performed in the past?

The mean historical Current Ratio of X4 Pharmaceuticals, Inc. over the last ten years is 6.31. The current 3.71 Current Ratio has changed 5.78% with respect to the historical average. Over the past ten years (40 quarters), XFOR's Current Ratio was at its highest in in the March 2020 quarter at 15.34. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

6.31

Median

6.27

Minimum

0.47

Maximum

13.68

X4 Pharmaceuticals, Inc. (XFOR) Current Ratio by Quarter and Year

Discovering the peaks and valleys of X4 Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 2.12%

Maximum Annual Current Ratio = 13.68

Minimum Annual Increase = -62.27%

Minimum Annual Current Ratio = 0.47

Quarterly (TTM)
Annual
YearCurrent RatioChange
20235.34-7.36%
20225.76-8.02%
20216.27-10.12%
20206.97-49.05%
201913.68110.57%
20186.50-38.25%
201710.522.12%
20160.47-62.27%

X4 Pharmaceuticals, Inc. (XFOR) Average Current Ratio

How has XFOR Current Ratio performed in the past?

The current Current Ratio of X4 Pharmaceuticals, Inc. (XFOR) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.79

5-year avg

7.61

10-year avg

6.31

X4 Pharmaceuticals, Inc. (XFOR) Current Ratio vs. Peers

How is XFOR’s Current Ratio compared to its peers?

X4 Pharmaceuticals, Inc.’s Current Ratio is less than Terns Pharmaceuticals, Inc. (27.85), less than Day One Biopharmaceuticals, Inc. (10.93), less than PDS Biotechnology Corporation (4.56), less than Inozyme Pharma, Inc. (14.05), less than Acumen Pharmaceuticals, Inc. (30.20), less than Mereo BioPharma Group plc (4.86), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Elevation Oncology, Inc. (46.22), less than Hepion Pharmaceuticals, Inc. (5.99), less than HOOKIPA Pharma Inc. (4.50),

Build a custom stock screener for X4 Pharmaceuticals, Inc. (XFOR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like X4 Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

X4 Pharmaceuticals, Inc. (XFOR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like X4 Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is X4 Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for X4 Pharmaceuticals, Inc. (XFOR)?

What is the highest Current Ratio for X4 Pharmaceuticals, Inc. (XFOR)?

What is the 3-year average Current Ratio for X4 Pharmaceuticals, Inc. (XFOR)?

What is the 5-year average Current Ratio for X4 Pharmaceuticals, Inc. (XFOR)?

How does the current Current Ratio for X4 Pharmaceuticals, Inc. (XFOR) compare to its historical average?